Some clinicians may not be aware of the germline associations of specific ovarian cancer histologies and may choose to offer BRCA1 and BRCA2 testing only, even in the context of non‐serous, non‐mucinous ovarian cancer. This evidence concerns the gene BRCA1 and ovarian cancer.